Lotus Bio-Technology Development

Lotus Bio-Technology Development Documenti

Documenti

95

Ticker

LBTD

ISIN

US54570R1077

Ricavi Utile netto P/E P/S EBIT Dividendo Acquisti degli insider Azioni Capitalizzazione di mercato Debito Passività Patrimonio netto AAQS Dipendenti ROE ROA ROCE News Documenti

Lotus Bio-Technology Development SEC Filings

Tipo
Rapporto
Data
DD-Formular23/12/2022
15-12G15-12G-Formular09/06/2021
10-Q/A10-Q/A-Formular07/04/2021
10-Q/A10-Q/A-Formular23/02/2021
10-Q/A10-Q/A-Formular27/01/2021
10-K/A10-K/A-Formular21/01/2021
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben20/09/2019
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/04/2019
NT 10-KNT 10-K-Formular29/06/2018
10-QQuartalsbericht13/02/2018
10-QQuartalsbericht13/11/2017
10-Q/A10-Q/A-Formular13/09/2017
10-QQuartalsbericht21/08/2017
NT 10-QNT 10-Q-Formular14/08/2017
10-KJahresbericht14/07/2017
NT 10-KNT 10-K-Formular29/06/2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben19/06/2017
10-QQuartalsbericht08/05/2017
NT 10-QNT 10-Q-Formular14/02/2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/02/2017
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben29/11/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben28/11/2016
10-QQuartalsbericht21/11/2016
NT 10-QNT 10-Q-Formular14/11/2016
10-QQuartalsbericht27/09/2016
10-KJahresbericht27/09/2016
NT 10-K/ANT 10-K/A-Formular30/06/2016
NT 10-KNT 10-K-Formular29/06/2016
S-8 POSS-8 POS-Formular11/04/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben08/04/2016
S-8 POSS-8 POS-Formular05/04/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben01/04/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben01/04/2016
10-QQuartalsbericht16/02/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben19/01/2016
S-8 POSS-8 POS-Formular17/11/2015
10-QQuartalsbericht16/11/2015
S-8 POSS-8 POS-Formular09/10/2015
10-Q/A10-Q/A-Formular10/09/2015
S-8 POSS-8 POS-Formular31/08/2015
S-8S-8-Formular25/08/2015
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben17/08/2015
10-QQuartalsbericht12/08/2015
10-KJahresbericht29/07/2015
10-Q/A10-Q/A-Formular17/07/2015
NT 10-KNT 10-K-Formular30/06/2015
10-QQuartalsbericht23/02/2015
10-QQuartalsbericht18/11/2014
NT 10-QNT 10-Q-Formular14/11/2014
10-QQuartalsbericht19/08/2014
NT 10-QNT 10-Q-Formular14/08/2014
10-KJahresbericht15/07/2014
NT 10-KNT 10-K-Formular30/06/2014
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12/05/2014
10-K/A10-K/A-Formular25/04/2014
10-QQuartalsbericht24/02/2014
NT 10-QNT 10-Q-Formular18/02/2014
10-QQuartalsbericht14/11/2013
10-QQuartalsbericht14/08/2013
10-KJahresbericht01/07/2013
10-Q/A10-Q/A-Formular25/02/2013
10-Q/A10-Q/A-Formular25/02/2013
10-K/A10-K/A-Formular25/02/2013
10-QQuartalsbericht19/02/2013
NT 10-QNT 10-Q-Formular15/02/2013
10-QQuartalsbericht13/11/2012
10-QQuartalsbericht02/08/2012
33-Formular02/07/2012
8-A12G8-A12G-Formular25/06/2012
10-KJahresbericht22/06/2012
424B3424B3-Formular03/04/2012
EFFECTEFFECT-Formular29/03/2012
CORRESPCORRESP-Formular26/03/2012
S-1/AS-1/A-Formular20/03/2012
S-1/AS-1/A-Formular13/03/2012
UPLOADUPLOAD-Formular12/03/2012
S-1/AS-1/A-Formular05/03/2012
UPLOADUPLOAD-Formular02/03/2012
S-1/AS-1/A-Formular21/02/2012
UPLOADUPLOAD-Formular14/02/2012
S-1/AS-1/A-Formular31/01/2012
UPLOADUPLOAD-Formular30/01/2012
S-1/AS-1/A-Formular13/01/2012
UPLOADUPLOAD-Formular12/01/2012
S-1/AS-1/A-Formular28/12/2011
UPLOADUPLOAD-Formular23/12/2011
S-1/AS-1/A-Formular16/12/2011
UPLOADUPLOAD-Formular18/11/2011
S-1/AS-1/A-Formular04/11/2011
UPLOADUPLOAD-Formular17/10/2011
S-1/AS-1/A-Formular03/10/2011
UPLOADUPLOAD-Formular19/08/2011
S-1/AS-1/A-Formular09/08/2011
UPLOADUPLOAD-Formular06/07/2011
S-1S-1-Formular10/06/2011

Lotus Bio-Technology Development Documenti 2026

Questa pagina contiene tutti i documenti ufficiali e i filing SEC dell'azione Lotus Bio-Technology Development (LBTD, ISIN: US54570R1077). Sono incluse le relazioni annuali (Form 10-K), le relazioni trimestrali (Form 10-Q) e le transazioni degli insider (Form 4). Attualmente sono disponibili 95 documenti. I dati vengono aggiornati regolarmente per offrire agli investitori una panoramica completa dei depositi regolamentari di Lotus Bio-Technology Development.